For patients with heart failure with preserved ejection fraction (HFpEF), endovascular treatment (EVT) improves left ...

At the largest hospital in Brooklyn, doctors are working to address disparities for patients facing advanced heart failure.

CINCINNATI ( WXIX /Gray News) - A 7-year-old is in a hospital in Ohio fighting for her life after experiencing her second ...

For patients with heart failure with preserved ejection fraction (HFpEF), endovascular treatment (EVT) improves left ...

Edgewise Therapeutics's hypertrophic cardiomyopathy (HCM) asset has started off with a bang after early safety data sent the ...

Endometriosis occurs when uterine tissue grows outside of the uterus -- on the ovaries, fallopian tubes and nearby organs --- causing severe pain and troubles with fertility. Researchers looked at ...

And happiness—or the lack of it—may affect our heart health, according to research published on September 18, 2024 ...

THURSDAY, Sept. 5, 2024 (HealthDay News) -- An AI-enhanced digital stethoscope can help doctors detect a potentially deadly form of heart failure that can occur late in pregnancy, a new clinical ...

Heart failure during pregnancy is a dangerous and often under-detected condition because common symptoms -- shortness of breath, extreme fatigue and trouble breathing while lying down -- are ...

LONDON — The benefit of mineralocorticoid receptor antagonists (MRAs) for the treatment of patients with heart failure and mildly reduced or preserved ejection fraction has finally been ...

In a recent meta-analysis published in The Lancet, researchers investigated the effect of steroidal and nonsteroidal mineralocorticoid receptor antagonists (MRAs) on patients with heart failure ...

With the heart failure (HF) patient population rapidly expanding, the timing is right for Bayer’s Kerendia (finerenone). The nonsteroidal mineralocorticoid receptor antagonist (MRA) was approved ...